Bioness Medical further expands pipeline of next-generation robotics offerings for Neuro Rehab
Bioness Medical, Inc. a leading neuro-rehabilitation Company aiming to improve and restore function for those living with neurological and orthopedic deficits, is pleased to announce it has acquired the assets and business of Austin, Texas based Harmonic Bionics, Inc, a robotics company focused on improving neuro rehabilitation patient upper extremity mobility and function deficits following brain insults like stroke and traumatic brain injury.
Health Technology Insights: Medhub-AI And Terumo Partner To Market AI-based FFR In Japan
Harmonic Bionics’ robotic system is a bilateral upper extremity robotic exoskeleton that works with a patient’s scapulohumeral rhythm to enable natural, comprehensive arm and shoulder therapy for those living with neurological musculoskeletal movements and impairments. Upon regulatory clearance, this robotic system will complement Bioness’ industry leading Vector Gait & Safety System and Bioness Integrated Therapy System (BITS) and BITS Balance technology that have become a standard of care.
For over 20 years, Bioness Medical has delivered advanced technology to support patient care in rehabilitation facilities. Known for its leadership in neuro rehabilitation, the Company’s expansion into upper extremity support through this acquisition is exciting news for both current and future customers. Once FDA clearance is obtained, Bioness Medical will expand upon its innovative technological portfolio in neuro rehabilitation.
Health Technology Insights: HHP Brings Hydra Health Retail Amenities To Nashville Healthcare Community
Todd Cushman, Bioness Medical’s CEO said, “When we launched as an independent organization earlier this year, we made a promise to our current and future customers that we would continue to support their evolving clinical technology needs and build on the success of our Functional Electrical Stimulation (FES) products, Vector and BITS Balance currently offered. The acquisition allows us to deliver critical upper extremity rehabilitation, an essential component in improving patient outcomes. The future of Bioness Medical is bright as we continue to bring innovative new products to market backed by world-class clinician and patient support.”
This marks Bioness Medical’s first acquisition since becoming an independent neuro rehabilitation Company following its acquisition by Accelmed Partners on December 31, 2024. The Company continues to expand its product portfolio through organic growth and strategic initiatives.
Health Technology Insights: MUSC Health Doubles Down On Patient Access Transformation With Notable
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source – PR Newswire
